Page last updated: 2024-09-03

peroxynitrous acid and sulfasalazine

peroxynitrous acid has been researched along with sulfasalazine in 1 studies

Compound Research Comparison

Studies
(peroxynitrous acid)
Trials
(peroxynitrous acid)
Recent Studies (post-2010)
(peroxynitrous acid)
Studies
(sulfasalazine)
Trials
(sulfasalazine)
Recent Studies (post-2010) (sulfasalazine)
3,303211,2304,437585938

Protein Interaction Comparison

ProteinTaxonomyperoxynitrous acid (IC50)sulfasalazine (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 2B1 Homo sapiens (human)3
Carbonic anhydrase 1Homo sapiens (human)3.04
Carbonic anhydrase 2Homo sapiens (human)4.49
Mitogen-activated protein kinase 1Homo sapiens (human)6.332
Sodium/bile acid cotransporterHomo sapiens (human)9.6
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.46
Cystine/glutamate transporterHomo sapiens (human)0.16
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.56

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BassiriRad, NM; Bui, L; Doyle, T; Forte, BL; Largent-Milnes, TM; Mantyh, PW; Neumann, WL; Salvemini, D; Slosky, LM; Staatz, WD; Symons, AM; Thompson, M; Vanderah, TW1

Other Studies

1 other study(ies) available for peroxynitrous acid and sulfasalazine

ArticleYear
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
    Pain, 2016, Volume: 157, Issue:11

    Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiporters; Bone Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Heterografts; Metalloporphyrins; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Sulfasalazine; Time Factors

2016